Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold 2,705 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a transaction involving the company's common stock.
• He sold 2,705 shares of common stock at a price of $46.576 per share.
• The transaction occurred on February 3, 2026.
• The sale was a 'sell to cover' transaction, mandated by the issuer's equity incentive plans, to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).
• This was not a discretionary trade by Mr. Finn.
• Following this transaction, Mr. Finn beneficially owns 307,788 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as 'sell to cover' transactions are non-discretionary sales for tax purposes and do not reflect management's sentiment on the company's future performance or underlying fundamentals.

Future Outlook

N/A

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a standard practice in executive compensation plans, allowing executives to meet tax obligations arising from the vesting of restricted stock units without needing to use personal funds. This is a common and expected event for executives receiving equity compensation across various industries.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary sale for tax purposes and does not signal a change in the executive's confidence or the company's fundamentals. It is a standard part of equity compensation.

Key Dates

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Restricted Stock Units, Sell to Cover, Patrick John Finn